期刊文献+

伴有食物不耐受的腹泻型肠易激综合征患者NF-κB和TLR4的表达及健脾法对其表达的影响 被引量:6

Expressions of NF-κB and TLR4 in patients with diarrhea-predominant irritable bowel syndrome complicating with food intolerance and the influences of invigorating spleen decoctions on them
下载PDF
导出
摘要 目的观察伴有食物不耐受的腹泻型肠易激综合征(D-IBS)患者十二指肠黏膜中NF-κB和TLR4的表达及健脾法对其表达的影响。方法选择60例伴有食物不耐受的D-IBS患者,随机分为治疗组30例和对照组30例。治疗组口服健脾为主的中药,每日1剂;对照组口服匹维溴铵片,50 mg/次,每日3次,治疗4周后进行疗效评价。治疗前后内镜下取十二指肠黏膜,应用免疫组化方法检测NF-κB和TLR4的表达情况。结果治疗组总有效率(93%)显著高于对照组(70%)(P<0.01);2组治疗后主要症状评分均显著低于治疗前。治疗前2组NF-κB和TLR4免疫组化染色阳性细胞数无显著性差异,治疗后治疗组NF-κB和TLR4免疫组化染色阳性细胞数显著低于对照组(P均<0.05)。结论 NF-κB和TLR4参与伴有食物不耐受的D-IBS患者的发病,健脾法治疗伴有食物不耐受的D-IBS有效,有可能与通过调节NF-κB和TLR4在肠黏膜的表达有关。 Objective It is to observe the expressions of NF-κB and TLR4 in patients with diarrhea-predominant irritable bowel syndrome(D-IBS) complicating with food intolerance and the influences of invigorating spleen decoctions on them.Methods 60 food intolerance patients with D-IBS were assigned randomly to treatment group and control group,each group had 30 cases.The treatment group was treated with invigorating spleen decoctions once a day,and the control group was treated with pinaverium bromide tablet(PVB) 50 mg three times a day.The curative effects were evaluated after 4 weeks.The expressions of NF-κB and TLR4 in duodenal mucosa were detected with immunohistochemistry method before and after treatment.Results The total effective rate of treatment group(93%) was significantly higher than that of control group(70%)(P0.01).The scores of main symptoms after treatment were significantly lower than that before treatment in both groups(P0.01).There was no significant difference between two groups in the expression of NF-κB and TLR4 pre-treatment.The expression of NF-κB and TLR4 in treatment group after therapy was significantly lower than that of control group(P0.05).Conclusion NF-κB and TLR4 play a role in the pathogenesis of D-IBS with food intolerance patients.The method of invigorating spleen is effective for treating D-IBS with food intolerance,which maybe due to regulate the expressions of NF-κB and TLR4 in duodenal mucosa.
出处 《现代中西医结合杂志》 CAS 2012年第13期1371-1373,1376,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 国家中医药管理局中医临床研究类课题(06-07LP54)
关键词 腹泻型肠易激综合征 食物不耐受 健脾法 NF-ΚB TLR4 diarrhea-predominant irritable bowel syndromes food intolerance the method of invigorating spleen NF-κB TLR4
  • 相关文献

参考文献10

  • 1高文艳.王长洪治疗腹泻型肠易激综合征经验[J].辽宁中医杂志,2010,37(7):1208-1210. 被引量:17
  • 2刘新光.肠易激综合征与罗马Ⅲ诊断标准[J].胃肠病学,2006,11(12):736-738. 被引量:279
  • 3Saito YA,Schoenfeld P,Locke GR.The epidemiology of irritable b-owel syndrome in North American:A systematic review[J].Am JGastroenterol,2002,97(8):1910-1915.
  • 4Nanda R,James R,Smith H,et a1.Food intolerance and the irrita-ble bowel syndrome[J].Gut,1989,30:1099-1104.
  • 5Shiotani A.Role of allergy in irritable bowel syndrome[J].Nippon.
  • 6Whorwell P,Lea R.Dietary treatment of the irritable bowel synd-rome[J].Curr Treat 0ptions Gastroenterol,2004,7:30.
  • 7张宇,孙瑞利,胡锦跃.Toll样受体4信号转导研究进展[J].国际病理科学与临床杂志,2009,29(1):32-36. 被引量:21
  • 8高飞,易静,汤雪明.核因子κB研究进展[J].细胞生物学杂志,2001,23(4):199-205. 被引量:18
  • 9Spiller RC,Jenkins D,Thornley JP,et a1.Increased rectal mucosalenteroendocrine cells,T lymphocytes,and increased gut permeabilityfollowing acute Campylobacter enteritis and in post-dysenteric irrita-ble bowel syndrome[J].Gut,2000,47(6):804-811.
  • 10Tornblom H,Lindberg G,Nyberg B,et al.Full-thickness biopsy ofthe jejunum reveals inflammation and enteric neuropathy in irritablebowel syndrome[J].Gastroenterology,2002,123(6):1972-1979.

二级参考文献16

  • 1Anna Misior.Novel Role and Regulation of the Interleukin-1 Receptor Associated Kinase(IRAK)Family Proteins[J].Cellular & Molecular Immunology,2005,2(1):36-39. 被引量:14
  • 2Chen F,Clinical Chemistry,1999年,45卷,1期,7页
  • 3Wang C,Science,1998年,281卷,1680页
  • 4Chen F,Arch Biochem Biophys,1997年,342卷,383页
  • 5Wang C,Science,1996年,274卷,784页
  • 6Drossman DA.Psychosocial and psychophysiologic mechanisms in GI Ⅲ ness.In:Kirsner JB,ed.The growth of gastroenterologic knowledge in the 20th century.Philadelphia:Lea & Febiger; 1993.41~432.
  • 7Whitehead WE,Palsson O,Jones KR.Systematic review of the comorbidity of irritable bowel syndrome with other disorders:what are the causes and implications? Gastroenterology,2002,122:1140~1156.
  • 8Drossman DA,Camilleri M,Mayer EA,Whitehead WE.AGA technical review on irritable bowel syndrome.Gastroenterology,2002,123:2108~2131.
  • 9Lea R,Whorwell PJ.New insights into the psychosocial aspects of irritable bowel syndrome.Curr Gastroenterol Rep,2003,5:343~350.
  • 10Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process.Gastroenterology,2006,130:1377~1390.

共引文献329

同被引文献115

引证文献6

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部